Articles Companion animals

04 August 2026

Efficacy of high-dose carvedilol treatment for cats with stage B1 obstructive hypertrophic cardiomyopathy.

Clinical evidence update from Journal of feline medicine and surgery

Clinical Context

Peer-reviewed veterinary literature continues to shape everyday decision-making for feline patients, especially when new evidence clarifies diagnosis, treatment selection, monitoring, or clinical outcomes.

What the Study Evaluated

A study published in Journal of feline medicine and surgery in 2026 evaluated efficacy of high-dose carvedilol treatment for cats with stage B1 obstructive hypertrophic cardiomyopathy..

Key Findings

ObjectivesThe aim of the study was to investigate the effects of high-dose (HD) carvedilol treatment in client-owned cats with stage B1 obstructive hypertrophic cardiomyopathy (oHCM) where a standard dose (SD) had failed to adequately alleviate left ventricular outflow tract (LVOT) obstruction.MethodsA prospective, interventional study was conducted in which cats underwent echocardiography, including evaluation of myocardial strain using speckle-tracking echocardiography. Myocardial injury was quantified using a cardiac troponin I (cTnI) assay. Echocardiographic variables and the cTnI level were compared before treatment and after SD and HD...

Why It Matters for Veterinary Professionals

For veterinary professionals, the practical value of this work lies in how the findings may support more structured clinical assessment, clearer monitoring, and more informed decisions for feline patients.

Practical Interpretation

The results should be interpreted in the context of the study design, population, inclusion criteria, and clinical setting. Application in practice should consider patient-specific risk factors, available diagnostics, local standards of care, and clinician judgment.

Clinical Takeaway

Overall, the study adds useful evidence for clinicians seeking to align daily practice with current veterinary research while maintaining a balanced, case-by-case approach.

Read the full article here.

Like0

Dislike0

List
Add

Please enter a comment

Name *

Email address *

Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

Dislike0

News of interest

Multilevel analysis of risk factors for clinical mastitis in dairy cows in Plateau State, Nigeria a hierarchical mixed-effects logistic regression modelling approach.

Strategies for Reducing Antimicrobial Use in Cattle Through Gut Microbiome Modulation A Systematic Review of Alternatives to Antibiotics.

Long term safety and efficacy of a functionalized nanogel with endothelin-1 and bradykinin receptor antagonist peptides for treatment of osteoarthritis of the metacarpophalangeal and distal interphalangeal joints in horses

Exploration of the efficacy of eucalyptus oil (micro-capsules) and mangosteen extract against Eimeria tenella infection in chickens.

EVENTS

Edrapublishing

About Us Authors Contact Us Legal Notes Privacy Search

Top

Efficacy of high-dose carvedilol treatment for cats with stage B1 obstructive hypertrophic cardiomyopathy.

Clinical evidence update from Journal of feline medicine and surgery

Comments

List

Add

Tag

Related Articles

04 August 2026
A retrospective (2020-2025), multicenter study of myxomatous mitral valve disease in Chihuahuas from Italy, Sweden, and the United States of America.

A retrospective (2020-2025), multicenter study of myxomatous mitral valve disease in Chihuahuas from Italy, Sweden, and the United States of America.

04 August 2026
Mastitis greatly increases the risk of teat fistula surgical repair failure a retrospective study of 92 lactating dairy cattle (1994-2019).

Mastitis greatly increases the risk of teat fistula surgical repair failure a retrospective study of 92 lactating dairy cattle (1994-2019).

03 August 2026
Owner points of view and perceived quality of life of diabetic cats pre- and post-hypophysectomy for hypersomatotropism.

Owner points of view and perceived quality of life of diabetic cats pre- and post-hypophysectomy for hypersomatotropism.

03 August 2026
Clinical trial reveals limited clinical and microbiome effects following oral fecal microbiota transplantation in dogs with chronic enteropathy responsive to tylosin.

Clinical trial reveals limited clinical and microbiome effects following oral fecal microbiota transplantation in dogs with chronic enteropathy responsive to tylosin.

03 August 2026
[Efficacy and safety of pixavir marboxil for uncomplicated influenza in adults a phase Ⅱ, randomized, double-blind, placebo-controlled clinical trial].

[Efficacy and safety of pixavir marboxil for uncomplicated influenza in adults a phase Ⅱ, randomized, double-blind, placebo-controlled clinical trial].

More news

The Lundquist Institute Launches the Nation's First Adult Exercise Medicine Fellowship